HealthEquity reports record HSA sales of 971k new HSAs in FY23; assets up 13% to $22.1B

HEALTHEQUITY, INC.

8.0M total HSAs (+11% YoY); Total Accounts 14.9M (+4% YoY).
HSA assets $22.1B (+13%); HSA investments $7.9B (+19%).
FY23 revenue guidance raised to ~$860M (top-end of prior range).
No investor call today; management to present at BTIG, Baird, Raymond James conferences.
Initial FY24 guidance provided Dec 6, 2022; update expected Mar 21, 2023 Q4 release.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

HEALTHEQUITY, INC. reported fiscal year ended January 31, 2023 results: revenue approximately $860 million. Guidance reaffirmed.

Period: fiscal year ended January 31, 2023
Revenue: approximately $860 million
Guidance: reaffirmed
Result: guidance update

Exact text from the filing

With the record-setting sales year we are reporting today, we expect to reach the top-end of previously provided ranges for revenue and earnings, including revenue of approximately $860 million for our fiscal year ended January 31, 2023.

View on SEC.gov

171 earnings releases filed in the last 30 days. Browse all earnings releases →

HEALTHEQUITY, INC. filing history →

Source: SEC EDGAR

accession 0001428336-23-000007

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.